SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-053930
Filing Date
2004-03-30
Accepted
2004-03-30 16:22:36
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 692719
3 CONSULTING AGREEMENT dex1012.htm EX-10.12 40006
4 EMPLOYMENT AGREEMENT DAVID PLATT dex1013.htm EX-10.13 81712
5 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2018
6 INDEPENDENT AUDITORS CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1448
7 CERTIFICATION OF CEO dex311.htm EX-31.1 9419
8 CERTIFICATION OF CFO dex312.htm EX-31.2 9438
9 CERTIFICATION OF CEO dex321.htm EX-32.1 4824
10 CERTIFICATION OF CFO dex322.htm EX-32.2 4785
  Complete submission text file 0001193125-04-053930.txt   848861
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 6175590033
PRO PHARMACEUTICALS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 04701425
SIC: 2834 Pharmaceutical Preparations